Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Buijs

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Thrombosis Research|May 11, 2024
Reply to 'letter-to-the-editor'J T Buijs, S Najidh, H H Versteeg
Current Pharmaceutical Design|August 21, 2010
Targeted therapy options for treatment of bone metastases; beyond bisphosphonatesJ T Buijs, C C H J Kuijpers, G van der Pluijm
Protoplasma|December 6, 2001
The ascorbate: ascorbate free radical oxidoreductase from the erythrocyte membrane is not cytochrome b561M M Van Duijn, J T Buijs, J Van der Zee, et al.
Thrombosis Research|December 5, 2022
Assessment of breast cancer progression and metastasis during a hypercoagulable state induced by silencing of antithrombin in a xenograft mouse modelJ T Buijs, B Ünlü, E H Laghmani, et al.
Thrombosis Research|May 1, 2026
Corrigendum to "The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model" [Thromb. Res. 244 (2024) 109200]B Ünlü, M Heestermans, E H Laghmani, et al.
Thrombosis Research|November 13, 2025
Regenerating islet derived Family Member 4 (REG4) does not influence parameters of hemostasis in colorectal cancerR J S Anijs, Y N Nguyen, M Yanovska, et al.
Oncogene|October 15, 2011
The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formationJ T Buijs, G van der Horst, C van den Hoogen, et al.
Thrombosis Research|February 14, 2026
Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancerJ T Buijs, N van Es, C Englisch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Thrombosis Research|May 11, 2024
Reply to 'letter-to-the-editor'J T Buijs, S Najidh, H H Versteeg
Current Pharmaceutical Design|August 21, 2010
Targeted therapy options for treatment of bone metastases; beyond bisphosphonatesJ T Buijs, C C H J Kuijpers, G van der Pluijm
Protoplasma|December 6, 2001
The ascorbate: ascorbate free radical oxidoreductase from the erythrocyte membrane is not cytochrome b561M M Van Duijn, J T Buijs, J Van der Zee, et al.
Thrombosis Research|December 5, 2022
Assessment of breast cancer progression and metastasis during a hypercoagulable state induced by silencing of antithrombin in a xenograft mouse modelJ T Buijs, B Ünlü, E H Laghmani, et al.
Thrombosis Research|May 1, 2026
Corrigendum to "The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model" [Thromb. Res. 244 (2024) 109200]B Ünlü, M Heestermans, E H Laghmani, et al.
Thrombosis Research|November 13, 2025
Regenerating islet derived Family Member 4 (REG4) does not influence parameters of hemostasis in colorectal cancerR J S Anijs, Y N Nguyen, M Yanovska, et al.
Oncogene|October 15, 2011
The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formationJ T Buijs, G van der Horst, C van den Hoogen, et al.
Thrombosis Research|February 14, 2026
Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancerJ T Buijs, N van Es, C Englisch, et al.
Pageof 1